Transforming older adult disability through virtual, peer-led community rehabilitation: led by MSK charities

Good Boost健康有限公司（Good Boost）是一家快速发展的英国中小企业，提供尖端的医疗技术。结合四大肌肉骨骼慈善机构和牛津布鲁克斯大学的合作、专业知识和网络接入，Good Boost独特的人工智能技术有可能在2025年之前为NHS节省1640万英镑。通过扩展数字社区康复解决方案，该项目有望在项目后3年产生39X的投资回报率。\*（相对关节炎，美国风湿性关节炎学会，关节炎行动，美国轴向脊椎关节病学会。）**未满足的需求**肌肉骨骼疾病（mskd），如关节炎和背痛，占英国疾病负担的22%以上，每年花费经济和NHS 1000多亿英镑。它们对老年人、低收入者和白人和黑人公民的影响尤为严重，造成了严重的健康不平等。MSKD患病率正在上升，等待时间在增加，在处理covid后积压的案件方面面临重大挑战。解决方案需要提供msk康复，不需要额外的NHS资源。受临床医生和患者的信任，MSK慈善机构是最重要的支持服务，提供更接近家庭的护理，与NHS战略保持一致。然而，有1880万人患有MSK，没有足够的临床工作人员或志愿者为所有人提供康复服务。**解决方案**Good Boost创新的人工智能msk康复技术将使慈善机构能够通过工作人员和志愿者提供虚拟小组康复课程。每个用户都将受益于人工智能个性化程序。迄今为止，MVP解决方案已与患者和慈善焦点小组共同设计和共同制作。这笔资金将支持现实世界试点的工业研究，以进一步开发、测试和验证临床技术，使其能够在2022年在全国推广，并满足迫切需求。**市场机遇**虽然市场上有人工智能康复产品，但没有一个提供虚拟社区解决方案。情感和同伴支持已被证明能显著提高吸收和持续参与。此外，没有产品与MSK慈善机构协同工作。由于老年人需要高度信任才能下载和使用健康应用程序，MSK慈善合作有可能显著增加覆盖范围和影响。全球有24.1亿人需要康复（世卫组织），这是一个巨大的国际商业机会。每年全球和英国的可寻址/可服务市场分别为154亿英镑/ 46.5亿英镑和51亿英镑/ 3.2亿英镑。复合年增长率为7.7%。**目标**该工业研究项目旨在完成产品测试、合作生产和研究，以在项目后3-6个月获得监管机构批准，向公众推出和商业化，创造一种公众可获得的产品，以解决mskd的临床康复需求，并减少健康不平等。

Good Boost Wellbeing Limited (Good Boost) is a rapidly growing UK SME delivering cutting-edge medical technology. Combined with the collaboration, expertise and network access of the four largest musculoskeletal charities\* and Oxford Brookes University, Good Boost's unique AI-powered technology has the potential to save the NHS £16.4m by 2025\. Through the expansion of digital community rehabilitation solutions, the project stands to generate a Year-3 post-project ROI of 39X. \*(Versus Arthritis, National Rheumatoid Arthritis Society, Arthritis Action, National Axial Spondyloarthropathy Society.)**Unmet Need**Musculoskeletal disorders (MSKDs), such as arthritis and back pain represent over 22% of the ill-health burden in the UK, costing the economy and NHS £100bn+ per year. Disproportionately impacting older adults, low income and BAME citizens, they create deep health inequalities. MSKD prevalence is rising, waiting times increasing and significant challenges are ahead to address backlogs post-COVID. Solutions are needed to deliver MSK-rehabilitation that don't require additional NHS resources.Trusted by clinicians and patients, MSK charities are the foremost support service to deliver care closer to home, aligning with the NHS strategy. However, with 18.8m people living with an MSK condition, there are not enough clinical staff or volunteers to provide rehabilitation services for all.**Solution**Good Boost's innovative AI MSK-rehabilitation technology will enable charities to deliver virtual group rehab classes through staff and volunteers. Every user will benefit from an AI-personalised programme. To date, an MVP solution has been co-designed and co-produced with patient and charity focus groups. This funding will support industrial research of a real-world pilot to further develop, test and validate the clinical technology, enabling national roll-out in 2022, and meeting the urgent need.**Market Opportunity**While there are AI-rehab products on the market, none deliver virtual community-based solutions. Emotional and peer support is proven to significantly improve uptake and continued engagement. Furthermore, no products work collaboratively with MSK charities. With older adults requiring high trust levels to download and use health apps, MSK charity collaboration has the potential to significantly increase reach and impact.2.41bn people need rehabilitation globally (WHO) representing a large international commercial opportunity. The annual global and UK addressable/serviceable markets are £15.4b/£4.65b and £0.51b/£0.32b respectively. CAGR is 7.7%.**Objectives**This industrial research project aims to complete product testing, co-production and research to achieve regulatory approval for public rollout and commercialisation 3-6 months post-project, to create a publically-accessible product which will address clinical rehab needs for MSKDs, and reduce health inequality.